Oslo, 13 January 2021, Carlos de Sousa, Chief Executive Officer and primary insider in Ultimovacs ASA, has today bought 1,000 shares in the company at a price of NOK 79.00 per share. Following this transaction, Carlos de Sousa and closely related parties hold 10,406 shares and 362,185 share options in Ultimovacs ASA.

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.